FLUOXYMESTERONE (fluoxymesterone) by Bausch + Lomb is clinical pharmacology endogenous androgens are responsible for normal growth and development of the male sex organs and for maintenance of secondary sex characteristics. First approved in 1983.
Drug data last refreshed 18h ago
CLINICAL PHARMACOLOGY Endogenous androgens are responsible for normal growth and development of the male sex organs and for maintenance of secondary sex characteristics. These effects include growth and maturation of the prostate, seminal vesicles, penis, and scrotum; development of male hair…
Worked on FLUOXYMESTERONE at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.